Licensing Red^®/ET^® Recombineering

Gene Bridges GmbH owns the exclusive rights to Red/ET Recombineering, a revolutionary DNA engineering technology. Gene Bridges issues licenses for the use of the Red/ET Recombineering technology to commercial users. Licensing arrangements for Red/ET Recombineering are provided as world-wide, non-exclusive sub-licenses.

6-Month Trial License

6-month trial licenses for EUR 5,000 are available for commercial parties wishing to test the technology.

Each license is provided with an attractive support package consisting of:

• Control experiment and materials
• Detailed protocols
• All necessary sequence information
• Latest Red/ET Recombineering plasmids regularly updated and supplied to licensee
• Red/ET Recombination proficient strains

Trial license [PDF]

Full License (standard format)

Gene Bridges can customize full licenses to include access to any combination of the following applications:

• Research only
• Cloning & Subcloning
• Knock-out & Knock-in constructs
• Transgenic constructs
• Conditional Knock-outs
• Viral engineering
• Transgenic Plants

They can be tailored to fit your requirements.

Full license [PDF]

For more information about the licensing of Red/ET Recombineering, please contact licenses@genebridges.com